NAME :- IRBESARTAN
IUPAC NAME :- 2-butyl-3-4-2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro 4.4 non-1-en-4-one
CAS NO. :- 138402-11-6
FORMULA :- C25H28N6O
SYNONYMS :- 2-Butyl-3-2-(1H-tetrazol-5-yl)1,1 -biphenyl-4-yl methyl-1,3-diazaspiro[4.4 non-1-en-4-one-d3
APPLICATION :- For the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria 300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of congestive heart failure.
DESCRIPTION :- Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer.